相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study
Diego Alvarado et al.
ALLERGY (2022)
The Anti-KIT Antibody, CDX-0159, Reduces Mast Cell Numbers and Circulating Tryptase and Improves Disease Control in Patients with Chronic Inducible Urticaria (Cindu)
Dorothea Terhorst-Molawi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Neutrophil Extracellular Traps, Angiogenesis and Cancer
Remo Poto et al.
BIOMEDICINES (2022)
The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)
Asger Sverrild et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Selected recent advances in understanding the role of human mast cells in health and disease
Francesca Levi-Schaffer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
KIT as a master regulator of the mast cell lineage
Mindy Tsai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Michel Arock et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells
Remo Poto et al.
FRONTIERS IN IMMUNOLOGY (2022)
Differential Effects of Alarmins on Human and Mouse Basophils
Adriana R. Gambardella et al.
FRONTIERS IN IMMUNOLOGY (2022)
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
Piper A. Robida et al.
CELLS (2022)
The Role of Airway Epithelial Cell Alarmins in Asthma
Christiane E. Whetstone et al.
CELLS (2022)
Biologics and airway remodeling in severe asthma
Gilda Varricchi et al.
ALLERGY (2022)
International Consensus Statement on the Management of Cardiovascular Risk of Bruton's Tyrosine Kinase Inhibitors in CLL
Farrukh T Awan et al.
Blood Advances (2022)
Biology of lung macrophages in health and disease
Helena Aegerter et al.
IMMUNITY (2022)
Biologics for allergic and immunologic diseases
Hideaki Morita et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis
Tahereh Derakhshan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
Wouter Korver et al.
FRONTIERS IN IMMUNOLOGY (2022)
Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
Pavel Kolkhir et al.
NATURE REVIEWS IMMUNOLOGY (2022)
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
Julia Schanin et al.
MUCOSAL IMMUNOLOGY (2021)
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
Jeffrey R. Strich et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Tim W. Harrison et al.
LANCET RESPIRATORY MEDICINE (2021)
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
Leonardo Cristinziano et al.
CELLS (2021)
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Sijin Cheng et al.
CELL (2021)
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib et al.
NATURE MEDICINE (2021)
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
Daniel J. DeAngelo et al.
NATURE MEDICINE (2021)
Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab
Donald MacGlashan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
Michael E. Wechsler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial
Christopher E. Brightling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Stem Cell Factor Neutralization Protects From Severe Anaphylaxis in a Murine Model of Food Allergy
Catherine Ptaschinski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
Marcus Maurer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation
Daniel F. Dwyer et al.
SCIENCE IMMUNOLOGY (2021)
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
Irene E. Braithwaite et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
Steven G. Kelsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
Andrew Menzies-Gow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma
Hsin-Kuo Ko et al.
SCIENTIFIC REPORTS (2021)
Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages
Barbara Balestrieri et al.
BIOMEDICINES (2021)
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
Sarah Diver et al.
LANCET RESPIRATORY MEDICINE (2021)
Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment
Mariantonia Braile et al.
CELLS (2021)
Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease
Andrew Rasky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
Jean Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
A Phase 2a Study of DP2 Antagonist GB001 for Asthma
Koichiro Asano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
IL-17-positive mast cell infiltration in the lesional skin of lichen planopilaris: Possible role of mast cells in inducing inflammation and dermal fibrosis in cicatricial alopecia
Ayako Hobo et al.
EXPERIMENTAL DERMATOLOGY (2020)
Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation
Thomas Plum et al.
IMMUNITY (2020)
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Pascal Gasser et al.
NATURE COMMUNICATIONS (2020)
Epithelial cell dysfunction, a major driver of asthma development
Irene H. Heijink et al.
ALLERGY (2020)
Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns
Stephen J. Galli et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
Jonathan A. Bernstein et al.
LANCET RESPIRATORY MEDICINE (2020)
An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells
Sheena C. Kerr et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Benralizumab strongly reduces blood basophils in severe eosinophilic asthma
Marek Lommatzsch et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2in Ischemic and Non-Ischemic Heart Failure
Gilda Varricchi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis
Melanie C. Dispenza et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries
Shalender Bhasin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiac Mast Cells: Underappreciated Immune Cells in Cardiovascular Homeostasis and Disease
Gilda Varricchi et al.
TRENDS IN IMMUNOLOGY (2020)
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial
Tom Wilkinson et al.
TRIALS (2020)
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
Evan S. Dellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
Christopher E Brightling et al.
Lancet Respiratory Medicine (2020)
Mass Cytometry Phenotyping of Human Granulocytes Reveals Novel Basophil Functional Heterogeneity
Nora Vivanco Gonzalez et al.
ISCIENCE (2020)
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
Henry R. Maun et al.
NATURE COMMUNICATIONS (2020)
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
Thomas B. Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Circulating mast cell progenitors correlate with reduced lung function in allergic asthma
Maya Salomonsson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2019)
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
Rapolas Zilionis et al.
IMMUNITY (2019)
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019
Gilda Varricchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Superantigenic Activation of Human Cardiac Mast Cells
Gilda Varricchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function
Gilda Varricchi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma
Giancarlo Marone et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Future Needs in Mast Cell Biology
Gilda Varricchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Henry R. Maun et al.
CELL (2019)
Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases
Gokhan Cildir et al.
IMMUNITY (2019)
Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling
Matthew C. Altman et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
Giancarlo Marone et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis
Thomas Werfel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease
Wendy Fonseca et al.
MUCOSAL IMMUNOLOGY (2019)
Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis
Ernest Duaha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Elevated levels of interleukin-33 are associated with allergic and eosinophilic asthma
Edita Gasiuniene et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Giancarlo Marone et al.
FRONTIERS IN PHARMACOLOGY (2019)
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Bradford A. Youngblood et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy
Sharon Chinthrajah et al.
JCI INSIGHT (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
T. Zuberbier et al.
ALLERGY (2018)
Human mast cells and basophils-How are they similar how are they different?
Gilda Varricchi et al.
IMMUNOLOGICAL REVIEWS (2018)
Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy
Melanie C. Dispenza et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease
Yan Li et al.
JOURNAL OF IMMUNOLOGY (2018)
TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models
Hiroaki Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
Reynold A. Panettieri et al.
LANCET RESPIRATORY MEDICINE (2018)
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
Gilda Varricchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma
Alexa P. Kollmeier et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Histamine H4 receptor mediates chemotaxis of human lung mast cells
Linda J. Kay et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa
Wei Wang et al.
JOURNAL OF IMMUNOLOGY (2018)
Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting
Merav Cohen et al.
CELL (2018)
TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast
Liuzhao Cao et al.
EXPERIMENTAL LUNG RESEARCH (2018)
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
Claudia Afferni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Controversial role of mast cells in skin cancers
Gilda Varricchi et al.
EXPERIMENTAL DERMATOLOGY (2017)
Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiation
Mandy Leist et al.
EXPERIMENTAL DERMATOLOGY (2017)
IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level
Regis Joulia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Skin-derived TSLP systemically expands regulatory T cells
Theresa M. Leichner et al.
JOURNAL OF AUTOIMMUNITY (2017)
Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation
Krishan D. Chhiba et al.
JOURNAL OF IMMUNOLOGY (2017)
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma
Katherine N. Cahill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tezepelumab in Adults with Uncontrolled Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Skin microbiome and mast cells
Satomi Igawa et al.
TRANSLATIONAL RESEARCH (2017)
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
Gary T. Ferguson et al.
LANCET RESPIRATORY MEDICINE (2017)
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
Geoffrey L. Chupp et al.
LANCET RESPIRATORY MEDICINE (2017)
Real-life Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis
Abdulaziz Alhossan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
KIT signaling is dispensable for human mast cell progenitor development
Joakim S. Dahlin et al.
BLOOD (2017)
Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma
Ann Esquivel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
Diego Bagnasco et al.
FRONTIERS IN MEDICINE (2017)
Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer
Maria Rosaria Galdiero et al.
FRONTIERS IN MEDICINE (2017)
Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling
C. Tabeling et al.
ALLERGY (2017)
Mast cells in rheumatoid arthritis: friends or foes?
Felice Rivellese et al.
AUTOIMMUNITY REVIEWS (2017)
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
B. Peter et al.
LEUKEMIA (2016)
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema
S. Loffredo et al.
ALLERGY (2016)
The modulatory effect of TLR2 on LL-37-induced human mast cells activation
Yuan-Yuan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Inhibition of spleen tyrosine kinase attenuates IgE-mediated airway contraction and mediator release in human precision cut lung slices
Cynthia J. Koziol-White et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma
A. L. da Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Mast cells in asthma - state of the art
P. Bradding et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
M. Hew et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Mast cell proteases as pharmacological targets
George H. Caughey
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Are Basophils and Mast Cells Masters in HIV Infection?
Gianni Marone et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Expression profiling of constitutive mast cells reveals a unique identity within the immune system
Daniel F. Dwyer et al.
NATURE IMMUNOLOGY (2016)
Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy
Glenn Cruse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Luke F. Pennington et al.
NATURE COMMUNICATIONS (2016)
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
Nicola A. Hanania et al.
LANCET RESPIRATORY MEDICINE (2016)
Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer
A. Shikotra et al.
SCIENTIFIC REPORTS (2016)
IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk
D. Kaur et al.
ALLERGY (2015)
Differential TLR-induced cytokine production by human mast cells is amplified by FcεRI triggering
J. Suurmond et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33
Geethani Bandara et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
Hyun-Woo Shin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
Shunya Mashiko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M. Arock et al.
LEUKEMIA (2015)
Mast cells in human and experimental cardiometabolic diseases
Guo-Ping Shi et al.
NATURE REVIEWS CARDIOLOGY (2015)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway
C. Visciano et al.
ONCOGENE (2015)
A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response
Isabel Ramis et al.
PHARMACOLOGICAL RESEARCH (2015)
Ability of Interleukin-33-and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses
Felice Rivellese et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2015)
Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies
J. Suurmond et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells
Haruka Sasaki et al.
BLOOD (2015)
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
Yoko Murata et al.
JOURNAL OF DERMATOLOGY (2015)
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing
Efthymios Motakis et al.
BLOOD (2014)
Siglec-7 is an inhibitory receptor on human mast cells and basophils
Sa'ar Mizrahi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2014)
Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice
S. H. Jung et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Contribution of stress to asthma worsening through mast cell activation
Theoharis C. Theoharides et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2012)
Mast Cell-Airway Smooth Muscle Crosstalk The Role of Thymic Stromal Lymphopoietin
Davinder Kaur et al.
CHEST (2012)
Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor
M. -M. Suttle et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Expressions and inhibitory functions of CD300a receptors on purified human basophils
Bernhard F. Gibbs et al.
EXPERIMENTAL DERMATOLOGY (2012)
Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FeγRIIb
Saso Cemerski et al.
IMMUNOLOGY LETTERS (2012)
The Tyrosine Kinase Inhibitor Masitinib Blunts Airway Inflammation and Improves Associated Lung Mechanics in a Feline Model of Chronic Allergic Asthma
Tekla M. Lee-Fowler et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy
Jessica H. Savage et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Aarti Shikotra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor
Beomkyu Kim et al.
NATURE (2012)
Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy
K. Vaali et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
Takumi Kiwamoto et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Mast Cells as Regulators of Skin Inflammation and Immunity
Ilkka T. Harvima et al.
ACTA DERMATO-VENEREOLOGICA (2011)
Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein
A. Eggel et al.
ALLERGY (2011)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Basophils: emerging roles in the pathogenesis of allergic disease
John T. Schroeder
IMMUNOLOGICAL REVIEWS (2011)
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses
Chris J. Corrigan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression
Sherry A. Hudson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation
Mark C. Siracusa et al.
NATURE (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
William W. Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening
Bruno O. Villoutreix et al.
PLOS ONE (2011)
Angiogenesis and lymphangiogenesis in bronchial asthma
A. Detoraki et al.
ALLERGY (2010)
Mast Cell-Derived TNF Can Exacerbate Mortality during Severe Bacterial Infections in C57BL/6-KitW-sh/W-sh Mice
Adrian M. Piliponsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation
Matthew R. Silver et al.
INFLAMMATION RESEARCH (2010)
Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway
Abdelhabib Semlali et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2
Francescopaolo Granata et al.
JOURNAL OF IMMUNOLOGY (2010)
Mast Cell Fibroblastoid Differentiation Mediated by Airway Smooth Muscle in Asthma
Davinder Kaur et al.
JOURNAL OF IMMUNOLOGY (2010)
Mast cells have a protumorigenic role in human thyroid cancer
R. M. Melillo et al.
ONCOGENE (2010)
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
Chia-Lin Hsu et al.
PLOS ONE (2010)
CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases
Rufina Schuligoi et al.
PHARMACOLOGY (2010)
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin
Theoharis C. Theoharides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics
M. Humbert et al.
ALLERGY (2009)
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
Sally E. Wenzel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The role of the Angiopoietins in vascular morphogenesis
Markus Thomas et al.
ANGIOGENESIS (2009)
Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells
M. -T. Krauth et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
FcεRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells
Y. Okayama et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
Aikaterini Detoraki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Mast Cell Stabilizing Properties of Antihistamines
Francesca Levi-Schaffer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
Michael Kneidinger et al.
BLOOD (2008)
Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: Cooperative roles for CADM1, stem cell factor, and IL-6
Fay Hollins et al.
JOURNAL OF IMMUNOLOGY (2008)
Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a
Ido Bachelet et al.
JOURNAL OF IMMUNOLOGY (2008)
The cysteinyl leukotrienes: Where do they come from? What are they? Where are they going?
K. Frank Austen
NATURE IMMUNOLOGY (2008)
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma
Sarah J. Ballantyne et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
IL-33 can promote survival, adhesion and cytokine production in human mast cells
Motoyasu Iikura et al.
LABORATORY INVESTIGATION (2007)
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation
Merel C. M. Strik et al.
MOLECULAR IMMUNOLOGY (2007)
Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
Zoulfia Allakhverdi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Proximal signaling events in Fc epsilon RI-mediated mast cell activation
Taku Kambayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Expression and functions of the vascular endothelial growth factors and their receptors in human basophils
Amato de Paulis et al.
JOURNAL OF IMMUNOLOGY (2006)
Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: Role in cell migration
Nick Di Girolamo et al.
JOURNAL OF IMMUNOLOGY (2006)
Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells
H Yokoi et al.
ALLERGY (2006)
Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis
Brenda J. Guyer et al.
ALLERGY AND ASTHMA PROCEEDINGS (2006)
Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway
J Cao et al.
MOLECULAR PHARMACOLOGY (2006)
Stem cell factor expression, mast cells and inflammation in asthma
CA Da Silva et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1
WD Yang et al.
JOURNAL OF IMMUNOLOGY (2006)
Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a
Ido Bachelet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast
I Bachelet et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure:: Effect of immunotherapy
KT Nouri-Aria et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of TH2-attracting chemokines and disease severity
S Ying et al.
JOURNAL OF IMMUNOLOGY (2005)
Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors
M Huttunen et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
A chimeric human-cat fusion protein blocks cat-induced allergy
DC Zhu et al.
NATURE MEDICINE (2005)
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment
EO Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts
SW Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells
S Okumura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein
K Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3
M Kulka et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells
CL Hofstra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone
A Chetta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human FcεRI+ cells through interaction with the κ light chains of IgE
A Genovese et al.
JOURNAL OF IMMUNOLOGY (2003)
Mast-cell infiltration of airway smooth muscle in asthma
CE Brightling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A novel human immunoglobulin Fcγ-Fcε bifunctional fusion protein inhibits FcεRI-mediated degranulation
DC Zhu et al.
NATURE MEDICINE (2002)
Ultrastructural immunolocalization of basic fibroblast growth factor to lipid bodies and secretory granules in human mast cells
AM Dvorak et al.
HISTOCHEMICAL JOURNAL (2001)
A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of FcγRI or FcεRI
Y Okayama et al.
JOURNAL OF IMMUNOLOGY (2001)
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors
M Triggiani et al.
JOURNAL OF IMMUNOLOGY (2001)
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis
M Hoshino et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils
KK Kikly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils
C Florio et al.
AIDS (2000)
Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells:: Up-regulation by IFN-γ
Y Okayama et al.
JOURNAL OF IMMUNOLOGY (2000)
HIV-1 gp120 induces IL-4 and IL-13 release from human FcεRI+ cells through interaction with the VH3 region of IgE
V Patella et al.
JOURNAL OF IMMUNOLOGY (2000)
Human intestinal mast cells are capable of producing different cytokine profiles: Role of IgE receptor cross-linking and IL-4
A Lorentz et al.
JOURNAL OF IMMUNOLOGY (2000)